VNUS Vnus Medical Technologies (MM)

SAN JOSE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (NASDAQ:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it plans to report its financial results for the fourth quarter ended December 31, 2008, after the close of market on February 10. VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT / 5:00 p.m. ET on February 10. This call will also be webcast live for investors and archived on the company's website at http://www.vnus.com/. How to Access the Live Teleconference To participate, please dial (303) 262-2137 approximately 5-10 minutes before the teleconference is scheduled to begin. The operator will take your name and connect your line with the meeting. A phone replay will be available for seven days after the live call at (303) 590-3000, code 11124466#. How to Access the Teleconference Webcast Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly. About VNUS Medical Technologies, Inc. VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com/. DATASOURCE: VNUS Medical Technologies, Inc. CONTACT: Peter Osborne, Chief Financial Officer and Vice President of Finance and Administration of VNUS Medical Technologies, Inc., +1-408-360-7499, Web site: http://www.vnus.com/

Copyright